Vyne Therapeutics Inc.
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 37 institutions reported holding Vyne Therapeutics Inc. in their 13F filings, up 3 from Q4 2024. 7 opened new positions and 4 sold out. The largest holders were Eventide Asset Management, LLC ($2.4M), Citadel Advisors ($1.7M) and Acorn Capital Advisors, LLC ($1.2M). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Vyne Therapeutics Inc.
- CUSIP
- 92941V308
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $1.6M |
| Exits | 4 | $4.8M |
All 13F filers, Q4 2024 → Q1 2025: 1,960,314 shares bought and 1,878,299 shares sold, net +82,015 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 37 holders
| Eventide Asset Management, LLC | 0.05% | No change | 1,394,336 | $2.4M |
| Citadel Advisors | 0.00% | Reduce -10.6% | 1,100,329 | $1.7M |
| Acorn Capital Advisors, LLC | 0.83% | Add +72.0% | 785,938 | $1.2M |
| DAFNA Capital Management LLC | 0.29% | New | 636,103 | $1.0M |
| Vanguard Group Inc. | 0.00% | Add +0.1% | 475,650 | $752K |
| Exome Asset Management LLC | 0.65% | Add +30.9% | 462,801 | $731K |
| Palo Alto Investors LP | 0.13% | No change | 445,434 | $704K |
| Adage Capital Partners Gp, L.L.C. | 0.00% | Add +123.3% | 344,134 | $544K |
| Patient Square Capital LP | 0.17% | New | 257,033 | $406K |
| Parkman Healthcare Partners LLC | 0.04% | Add +42.5% | 217,978 | $344K |
| Prelude Capital Management, LLC | 0.02% | Add +138.2% | 141,502 | $224K |
| Geode Capital Management, LLC | 0.00% | Reduce -1.1% | 133,490 | $211K |
| Renaissance Technologies | 0.00% | Add +361.6% | 115,143 | $182K |
| Schonfeld Strategic Advisors LLC | 0.00% | Reduce -51.9% | 84,978 | $134K |
| BlackRock, Inc. | 0.00% | Reduce -0.9% | 82,579 | $130K |
| ADAR1 Capital Management, LLC | 0.02% | New | 70,419 | $111K |
| Susquehanna International Group, LLP | 0.00% | Reduce -18.4% | 57,762 | $91K |
| Bridgeway Capital Management, LLC | 0.00% | Add +40.6% | 51,958 | $82K |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.00% | Reduce -81.5% | 45,557 | $72K |
| XTX Topco Ltd | 0.00% | Add +57.3% | 33,052 | $52K |
| HRT Financial LP | 0.00% | New | 26,242 | $41K |
| Northern Trust Corp. | 0.00% | No change | 23,971 | $38K |
| Virtu Financial LLC | 0.00% | New | 19,574 | $31K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 18,298 | $29K |
| Shay Capital LLC | 0.01% | New | 18,015 | $28K |
| Bank of America Corp. | 0.00% | Add +1051.1% | 17,163 | $27K |
| State Street Corp. | 0.00% | No change | 15,765 | $25K |
| Morgan Stanley | 0.00% | Add +198.0% | 12,811 | $20K |
| UBS Group AG | 0.00% | Add +1100.6% | 7,576 | $12K |
| JPMorgan Chase & Co. | 0.00% | Add +1804.8% | 5,981 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +210.0% | 4,296 | $7K |
| Royal Bank of Canada | 0.00% | Reduce -90.3% | 2,440 | $4K |
| Mb, Levis & Associates, LLC | 0.00% | No change | 1,041 | $2K |
| Centerpoint Advisors, LLC | 0.00% | No change | 350 | $1K |
| Cwm, LLC | 0.00% | No change | 500 | $1K |
| Wells Fargo & Company | 0.00% | No change | 65 | $103 |
| Truvestments Capital LLC | 0.00% | New | 25 | $40 |
"% of holder's portfolio" is VYNE THERAPEUTICS INC's weight in each manager's 13F, not the share of Vyne Therapeutics Inc. the manager owns.